CYCLO THERAPEUTICS, INC.: 10-Q filed 2019-08-13
What CYCLO THERAPEUTICS, INC. reported in its quarterly report filed 2019-08-13 (fiscal Q2 2019): 24 published measures, 62 facts as tagged in accession 0001437749-19-016546.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-08-13
- Fiscal period
- fiscal Q2 2019
- Accession
- 0001437749-19-016546 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYCLO THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 7,591,024 | USD | |
| At 2018-12-31 | 2,917,856 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 4,840,009 | USD | |
| At 2019-03-31 | -781,580 | USD | |
| At 2018-12-31 | 992,524 | USD | |
| At 2018-06-30 | 1,003,445 | USD | |
| At 2018-03-31 | 332,674 | USD | |
| At 2017-12-31 | 1,145,618 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 6,607,613 | USD | |
| At 2018-12-31 | 2,217,412 | USD | |
| At 2018-06-30 | 1,541,030 | USD | |
| At 2017-12-31 | 1,270,973 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -1,368,011 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -3,272,177 | USD | 181 |
| 2019-01-01 to 2019-03-31 | -1,904,166 | USD | 90 |
| 2018-04-01 to 2018-06-30 | -1,289,229 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -2,102,173 | USD | 181 |
| 2018-01-01 to 2018-03-31 | -812,944 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | -2,746,667 | USD | 181 |
| 2018-01-01 to 2018-06-30 | -1,706,068 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 1,324 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 1,634 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 7,119,662 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 1,960,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 17,206 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 16,125 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | -20,859,877 | USD | |
| At 2018-12-31 | -17,587,700 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 16,926 | USD | |
| At 2018-12-31 | 18,571 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -1,370,284 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -3,278,074 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -1,294,740 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -2,109,116 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 7,403,435 | USD | |
| At 2018-12-31 | 2,769,611 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 2,704,814 | USD | |
| At 2018-12-31 | 1,925,332 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 154,110 | USD | |
| At 2018-12-31 | 80,044 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 397,584 | USD | |
| At 2018-12-31 | 416,531 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | 786,811 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 2,129,574 | USD | 181 |
| 2018-04-01 to 2018-06-30 | 844,376 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 1,253,574 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 120,529,324 | shares | |
| At 2018-12-31 | 90,759,324 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 25,687,834 | USD | |
| At 2018-12-31 | 18,701,211 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 59,519 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 178,200 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -1,368,011 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -3,272,177 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -1,289,229 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -2,102,173 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 2,969 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 5,026 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 74,066 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 34,567 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | -18,947 | USD | 181 |
| 2018-01-01 to 2018-06-30 | -63,635 | USD | 181 |
Inspect the source
- Entity
- CYCLO THERAPEUTICS, INC. / CIK 0000922247
- Captured
- 2026-09-21T17:17:43.874Z
- SEC response SHA-256
00eb7fd40e8240f18174ace9c17e250765347f97ee2730b0222250298ac67de3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000922247.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))